Holly Wobma
Holly completed an MD-PhD at Columbia University in New York during which she conducted graduate training in the lab of Gordana Vunjak-Novakovic and helped co-found a cell therapy company called Immplacate. She will soon be starting (June 2019) as a pediatric resident at the Boston Combined Residency Program and is interested in developing and translating cell and gene therapies for pediatric disease.
Posts by: Holly
Relay race to finish off inflammatory cells
I don’t have many distinct memories from childhood. Certainly not of global events. But given the sweltering weather, the recent Canada 150 celebration, and a cool new paper published in Cell Chemical Biology, my mind wandered back to the ’96 summer Olympics (Atlanta), when Donovan Bailey raced through the finish line with his arms in […]
What time zone is your heart tissue In?
Our lives our governed by our concept of time. Whether you are relatively spontaneous or a micromanager of your daily schedule, how we coordinate our work and interactions with other people comes down to the 24-hour clock we picture in our minds. Of course, this 24-hour clock is more than just a social construct. It […]
From organ survival to organ revival – how patients can regenerate their own donor lung prior to surgery
For most areas of medicine, the supply of a treatment can easily meet demand (access issues aside). Need an antibody? A steroid? Millions of pills are manufactured every day. The case could not be more different for solid organ transplantation, for which the list of patients with end-stage organ failure vastly exceeds the number of […]
Sculpted to a T: Synthetic T-cells for a more controlled immune response
I have a confession. This is not a blog about stem cells. It is, however, a blog about cells with infinite possibilities of fate. Because we are entering the world of synthetic biology, where crafty cellular engineering has enabled a new level of control over immune cell function. This work comes out of Wendell Lim’s […]
Filling the void: A scientist’s introduction to commercialization/clinical translation
For anybody who has invested a great deal of time into a research project, you probably feel a certain sense of expertise on the topic. Sure, it is impossible to know a whole field (every answer raises more questions), and lab work is rife with puzzlement and failures, but at the end of the day, […]